Bojie Medical: Do "pathogen diagnosis experts" to help the immunity mission
(Video Production: Wang Yuanzhou) The first time design R & D diagnostic kits and passed the verification, and is used by the Shanghai Municipal Government for the prevention and control of epidemic situation. When faced with new crown epidemics, Shanghai Boyjie Medical Technology Co., Ltd. is more and more well known by the public.
In 2017, in the field of infectious pathogens, the three alumni gathered together, with the idea of ??"professional people to do professional things," three founders jointly established Shanghai Boyjie medical technology limited company. "In the initial 闵行会所论坛 stage, we didn’t work together.
"Zhao Baihui as one of the founders of Bejie Medical, talking about the beginning of the beginning of business because of the concept of" one shot ":" We have more than 15 years of experience; we have graduated from Shanghai Jiaotong University; we are in public The sanitary lines have worked more than 10 years, and they are quite familiar with each other.
The company surrounds the three people, the main line of infective pathogens, from diagnostic reagents, diagnostic instruments, sequencing services, and medical examination services.
Three people have passed by forty brave and re-entry have passed forty. In the system, I have already achieved advanced titles, why do you want to start a business? "In order to solve problems! During the US 上海飞机按摩论坛 Boston training, I feel that the hospitals, enterprises, research institutions communicate and transform the efficiency.
The listing of Kechuang board is part of the company planning. It is an inevitable result of the goal process, not the target, and ultimately we have to make a good reagent and instrument. "Behach Medical is committed to the research and development and application of infective pathogen molecular diagnosis reagents, deep tillage in multi-fluorescent PCR diagnostic reagents. The company’s main body is located in Shanghai Fengchui Valley Biology Park, with 3,000 square meters of ISO9001 and ISO13485 Certified clean factory, and 1200 square meters of equipment production and sequencing service area. The company wholly-owned medical inspection laboratory registered as a secondary biosafety laboratory, located in Pudong International Medical Park, covering an area of ??1000 square meters, has opened Genetic and microbial testing two qualifications, equipped with advanced professional related instrumentation equipment.
In Zhao Baihui, the last five years is a five-year replacement of domestic products, that is, domestic products can replace some imported instrument equipment or physical products in the hospital; then the next five years should be innovative for 5 years, but not sudden Come in innovation, but in the foundation of the previous five-year accumulation, it needs to work closely with colleges and colleges and research institutes.
At present, Berjie Medical has cooperated with key laboratories in universities such as Shanghai Jiaotong University, Shanghai University of Science and Technology, Fudan University. "We look forward to some good technologies. If we want to industrialize, we can go to undertake transformation, or when Bojie can participate in research and development, it is recommended from the perspective of application. These colleges and talent resources are also our Shanghai enterprise The advantages.
"Fast reactions during the epidemic, the new coronary virus epidemic emergence, Berjie medical response is fast, but also benefits from the company’s early cultivation in the diagnosis of respiratory infectious diseases. More than 400 nucleic acid detection reagents and 3 Different nucleic acid extraction reagents have been widely used in most disease prevention and control centers in China. In the early days of the epidemic, Berjail’s respiratory pathway provided by the disease control has specified the direction of coronary virus infection at the time. Also laid the foundation for the retroactory and diagnosis of later case samples and virus.
Later, the new coronavirus nucleic acid detection kit developed by Berger has passed the approval of the State Food and Drug Administration (NMPA), and is used by the Shanghai Municipal Government for exemption prevention and control.